Partnering Pharma Marketing and Non-Profit Public Health

As a health researcher, it was interesting to me that pharma marketers noted during different presentations today that they were “listening” to client (or potential client) online activity and not yet actively participating or interacting with it (aka not acting on the data quite yet). To me, this means that the presentations reporting on patient, HCP, or client data during the summit are really just the tip of the iceberg, that there are rich stocks of digital data marketers have available and are still gathering. As a non-profit researcher, this means that there is tons of valuable data out there, already gathered and profiled. Unlike pharma marketers, publically funded researchers like me do not have the capital to invest on data collection on the same level that private pharmaceutical marketers do. So while most of the presentations today say that gathering web-based data is “less expensive” than alternatives, for us publically funded researchers, that level of data collection would often be unattainable despite having the training and expertise to make sense of it. What will happen to this data? Will we, the monetarily-and-resource-deficient public health researchers ever be able to use it? It was encouraging to hear that most pharma marketers are open to partnerships, but I wholeheartedly hope that this means they are open to partnerships that do not result in revenue but do have a potential to improve health. Sharing data and partnering with public and governm...
Source: ePharma Summit - Category: Pharmaceuticals Tags: ePharma ePharma Live HCP health researcher MYUMC non-profit NYU pharma marketer Source Type: blogs